Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Fulvestrant impurity 1, also known as Fulvestrant 9-sulfone, is a known impurity of the selective estrogen receptor downregulator fulvestrant. It serves as a useful reference compound in the analysis of drug purity and stability in pharmaceutical formulations. This reagent is applicable in quality control and characterization studies within drug development and regulatory compliance. -
Drug Impurity
Esomeprazole impurity 2 is a known impurity associated with Esomeprazole, which is commonly used as a proton pump inhibitor. This compound is valuable for analytical and quality control purposes in pharmaceutical research, facilitating the assessment of drug purity and stability. Its identification and characterization are essential for ensuring compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Aripiprazole impurity 35 is a known impurity associated with the antipsychotic drug Aripiprazole. This compound is primarily studied for its potential effects on the pharmacokinetics and safety profile of the parent drug. Researchers utilize this impurity in analytical studies to assess the purity of Aripiprazole formulations and to understand the implications of drug impurities on therapeutic efficacy and patient safety. -
Drug Impurity
tert-Butyl (6-(4-hydroxyphenoxy)hexyl) carbonate is identified as a drug impurity associated with pharmaceutical formulations. This compound is significant for its potential effects on drug stability and efficacy, making it relevant for quality control and analytical chemistry applications in drug development. Researchers may utilize this reagent to evaluate impurities in synthetic processes or assess compliance with regulatory standards. -
Cefazolin Impurity
Cefazolin Impurity H is a byproduct generated in the synthesis of Cefazolin, a semi-synthetic cephalosporin antibiotic. This impurity can be used as a reference standard in analytical chemistry for the identification and quantification of Cefazolin in pharmaceuticals. It is essential for ensuring the quality and efficacy of cefazolin formulations in research and development. -
Drug Impurity
Prasugrel chloride impurity maleate is a known impurity of Prasugrel chloride maleate, primarily used in pharmaceutical research and quality control applications. Its presence is critical for understanding the purity levels and potential implications for drug safety and efficacy. This compound enables the assessment of drug formulations to ensure compliance with regulatory standards in the development of antiplatelet therapies. -
Drug Impurity
Haloperidol impurity 18 is a known impurity associated with the antipsychotic drug Haloperidol. This compound is relevant for quality control and analytical research applications, as it aids in assessing the purity of Haloperidol formulations. It is essential for researchers investigating drug metabolism and safety profiles, contributing to a better understanding of pharmaceutical quality standards. -
Drug Impurity
Buspirone impurity 11 is a characterized impurity of the anxiolytic agent buspirone. It serves as a key reference standard for quality control and safety assessment in pharmaceutical formulations containing buspirone. This compound is essential for understanding the implications of drug impurities on therapeutic efficacy and patient safety during drug development and regulatory compliance. -
Drug Impurity
Bumetanide impurity 5 is a characterized impurity associated with the diuretic agent Bumetanide. This compound is important for analytical and quality control studies related to the synthesis and purity assessment of Bumetanide. It is utilized in pharmacokinetic research and drug formulation development to ensure compliance with regulatory standards for pharmaceutical products. -
Drug Impurity
Sitagliptin impurity 9 phosphate is a known impurity associated with Sitagliptin phosphate. This compound serves as an important reference standard for the assessment of drug purity and quality control in pharmaceutical formulations. Its presence is critical for the evaluation of Sitagliptin's safety and efficacy in therapeutic applications, particularly in the management of Type 2 diabetes. -
Drug Impurity
Tacrolimus impurity 9 is a known impurity of the immunosuppressant Tacrolimus, primarily affecting its chemical profile. This compound serves as a critical reference standard for analytical methods in the identification and quantification of Tacrolimus-related impurities. Its study is essential for ensuring the quality and safety of Tacrolimus formulations in pharmaceutical research and development. -
Drug Impurity
Citalopram impurity 11 is a known impurity associated with the selective serotonin reuptake inhibitor citalopram. Its presence is relevant in the analysis of pharmaceutical formulations and can serve as a reference standard in purity assessments. This compound is important for ensuring the quality control of citalopram and may facilitate studies on drug metabolism and safety profiles. -
Drug Impurity
Avibactam impurity 53 is a chemical impurity associated with the synthesis of Avibactam, a beta-lactamase inhibitor. This compound is relevant for analytical studies and quality control in drug development and formulation. It assists researchers in understanding and characterizing the purity profile of Avibactam-related compounds, facilitating compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Ropinirole impurity 2 is a chemical impurity associated with the synthesis of Ropinirole, a dopamine receptor agonist. This compound can be utilized for analytical purposes in the assessment of drug purity and quality control in pharmaceutical research. Its presence is significant for the evaluation of Ropinirole formulations and may impact the overall efficacy and safety profile of the drug. -
Drug Impurity
Tenofovir impurity 8 is a known impurity of Tenofovir, a nucleotide reverse transcriptase inhibitor. This compound may be used for quality control and characterization in pharmaceutical research to ensure the purity and safety of Tenofovir formulations. Its presence is critical for understanding the chemical profile and potential impacts on therapeutic efficacy and safety. -
Drug Impurity
Rosuvastatin TMBA (ZD 4522 TMBA) is a drug impurity associated with the cholesterol-lowering agent rosuvastatin. It is predominantly used in analytical chemistry to assess the purity of pharmaceutical formulations. Researchers utilize this compound to study the degradation pathways and stability of rosuvastatin in various formulations, contributing to quality control and regulatory compliance in drug development. -
Drug Impurity
Dabigatran impurity 14 hydrochloride is a known impurity associated with the anticoagulant drug Dabigatran. This compound is utilized primarily in quality control and validation studies within pharmaceutical development. Its presence can impact the safety and efficacy profiles of Dabigatran, making it essential for research focused on drug formulation and compliance with regulatory standards. -
Drug Impurity
Ketoconazole impurity 17 is a known impurity of the antifungal agent Ketoconazole. This compound is utilized primarily in quality control and analytical research to assess the purity of Ketoconazole formulations. Its presence may have implications for the drug's safety and efficacy, making it critical for pharmaceutical development and regulatory compliance. -
Drug Impurity
Apixaban impurity 18 is a characterized impurity associated with Apixaban, a direct oral anticoagulant that inhibits Factor Xa. This reagent is crucial for quality control and method development in pharmaceutical research, enabling the assessment of purity levels in drug formulations. Its analysis is essential for ensuring compliance with regulatory standards in the development and manufacture of anticoagulant therapies. -
Budesonide Impurity
17-Carboxy Budesonide is a relevant impurity of Budesonide, serving as an important compound for quality control and analytical purposes in pharmaceutical research. Its identification and quantification are crucial in the development and validation of Budesonide formulations. This reagent is essential for studies focused on drug impurities and their potential effects on pharmacokinetics and pharmacodynamics. -
Drug Impurity
Solifenacin impurity 5, also known as Solifenacin impurity G, is a chemical impurity associated with Solifenacin, a muscarinic receptor antagonist. This compound is relevant for analytical and quality control applications in pharmaceutical research. It is essential for studying the purity and stability of Solifenacin formulations, helping researchers ensure compliance with regulatory standards. -
Drug Impurity
Alectinib impurity 1 is a known impurity of the ALK inhibitor Alectinib, which primarily targets anaplastic lymphoma kinase. This impurity is crucial for quality control and analytical purposes in the pharmaceutical development of Alectinib and its formulations. It can also be utilized in studies focused on the structural characterization and stability of drug compounds. -
Drug Impurity
Azithromycin impurity 18 is a known impurity associated with the antibiotic Azithromycin. This compound serves as an important reference standard for quality control and stability testing in pharmaceutical research. Its characterization is essential for ensuring the purity and efficacy of Azithromycin in drug formulations, making it valuable for analytical chemists and researchers studying pharmaceutical compounds. -
Drug Impurity
Atorvastatin impurity 3 is a chemical impurity associated with Atorvastatin, a widely used statin for lowering cholesterol levels. This impurity may serve as a reference standard for quality control in pharmaceutical research and development. It is relevant for studies focused on the analysis of drug purity and stability during formulation processes. -
Drug Impurity
Salbutamol impurity 9 is a recognized impurity associated with Salbutamol, a medication primarily used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). This impurity serves as a reference standard in analytical chemistry and drug quality control, aiding in the identification and quantification of related substances in pharmaceutical formulations. Its role in research supports the assessment of drug purity and the development of robust analytical methods. -
Drug Impurity
Rifaximin impurity 2 is a chemical impurity associated with Rifaximin, a broad-spectrum antibiotic. This compound serves as a reference standard in quality control and analytical testing of Rifaximin formulations. Its characterization is essential for ensuring the integrity and efficacy of drug products during development and manufacturing processes in pharmaceutical research. -
Drug Impurity
Tamsulosin impurity 17 is a chemical impurity associated with the synthesis of Tamsulosin, an alpha-1 adrenergic antagonist. This impurity is significant for analytical chemistry applications, particularly in the characterization and quality control of pharmaceutical formulations containing Tamsulosin. Its presence is crucial in ensuring compliance with regulatory standards and enhancing the understanding of the compound's purity profile in research contexts. -
Netilmicin impurity
Cyclic iodixanol is an impurity associated with iodixanol, a non-ionic radiocontrast agent containing iodine. Its presence can be critical for analytical studies in pharmaceutical development and quality control. Researchers may utilize cyclic iodixanol to investigate the effects of impurities on drug efficacy and safety profiles, particularly in formulations involving iodixanol. -
Drug Impurity
Trazodone impurity 18 is a chemical impurity associated with Trazodone. It serves as a critical reference standard for quality control and analytical testing in pharmaceutical research. Its characterization supports investigations into the metabolic pathways and potential side effects of Trazodone, facilitating a comprehensive understanding of drug safety and efficacy. -
Drug Impurity
Roflumilast impurity 4 is a noted impurity associated with the phosphodiesterase-4 (PDE4) inhibitor Roflumilast. This compound is relevant in the quality control of pharmaceutical formulations, ensuring the purity and safety of the active drug substance. It is utilized in analytical chemistry applications to assess and characterize impurities in drug development processes, particularly in respiratory therapeutics. -
Drug Impurity
Azithromycin impurity 13 is a chemical impurity associated with the antibiotic azithromycin. It serves as a critical component in quality control and analytical chemistry, facilitating the assessment of the compound's purity and stability. This impurity may impact the pharmacological profile of azithromycin and is essential for researchers focusing on drug metabolism and formulation studies. -
Drug Impurity
Buspirone impurity 8 is a known impurity of the anxiolytic compound Buspirone. This reagent serves as a critical tool for quality control and analytical studies in pharmaceutical research and development. Its characterization and quantification are essential for ensuring the purity and safety of Buspirone formulations. Researchers can utilize this impurity to assess the efficacy and stability of related pharmaceutical compounds. -
Drug Impurity
Amlodipine impurity 2 is a recognized impurity of the antihypertensive agent Amlodipine, primarily affecting the drug's quality and stability. Its presence is relevant for analytical chemistry and pharmaceutical development, particularly during the quality control of Amlodipine formulations. This compound serves as a critical reference standard for assessing purity and ensuring compliance with regulatory specifications in drug manufacturing processes. -
Drug Impurity
Terbinafine impurity 7 is a known impurity of the antifungal agent terbinafine. It serves as an important standard for analytical research and quality control in pharmaceutical development. The characterization and quantification of this impurity are essential for ensuring the safety and efficacy of terbinafine formulations. Its presence can affect the pharmacokinetics and overall therapeutic profile of the parent compound. -
Drug Impurity
Omeprazole impurity 4 is a known impurity of the proton pump inhibitor omeprazole. This compound can be utilized in the assessment of pharmaceutical purity, stability studies, and regulatory compliance for omeprazole formulations. Its characterization is essential for ensuring the safety and efficacy of proton pump inhibitor medications in clinical use. -
Drug Impurity
Dapagliflozin impurity 2 is a drug impurity associated with Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This impurity is relevant for analytical chemistry applications and quality control processes in pharmaceutical research. Its characterization and quantification are important for ensuring the safety and efficacy of Dapagliflozin formulations in compliance with regulatory standards. -
Drug Impurity
Febuxostat impurity 5 is a known impurity associated with the drug febuxostat, which inhibits xanthine oxidase to reduce uric acid production. This compound is crucial for analytical and quality control studies, ensuring the purity of febuxostat formulations. Its characterization can aid in understanding the metabolic pathways and the overall safety profile of febuxostat in therapeutic applications. -
Drug Impurity
Aripiprazole impurity 28 is a characterized impurity of the antipsychotic agent Aripiprazole. This compound serves as a crucial analytical standard for the assessment of drug purity and stability in pharmaceutical formulations. Its presence may affect the pharmacokinetic and pharmacodynamic properties of the drug, making it integral for quality control and regulatory compliance in drug development studies. -
Drug Impurity
Estradiol benzoate impurity 4 is a minor impurity associated with Estradiol benzoate, a synthetic form of estrogen. This compound is significant for quality control purposes in pharmaceutical formulations and can be utilized in analytical chemistry to assess the purity of estradiol benzoate preparations. Its presence serves as a marker for the synthesis and handling processes in drug production. -
Drug Impurity
Sitagliptin impurity 14 is a chemical impurity associated with Sitagliptin, a DPP-4 inhibitor used in the treatment of type 2 diabetes. This impurity is relevant for the assessment of drug quality and stability in pharmaceutical development. It is essential for researchers focusing on the characterization and validation of drug compounds, ensuring compliance with regulatory standards in the production of therapeutic agents. -
Drug Impurity
Salmeterol impurity 11 is a known impurity associated with the bronchial antagonist Salmeterol. Its identification and quantification are crucial in the quality control of pharmaceutical products containing Salmeterol. Research applications include analytical method development and toxicological studies to ensure the safety and efficacy of therapeutic formulations. -
Drug Impurity
Dopamine Impurity 2 is a synthetic byproduct of dopamine, a key neurotransmitter involved in numerous neurological processes. This compound serves as a reference standard for assessing the purity of dopamine in research and pharmaceutical applications. Its characterization is essential for quality control and method development in drug formulation and analysis. -
Drug Impurity
Azilsartan impurity 3 is a characterized impurity of the antihypertensive agent Azilsartan. This compound may be utilized in quality control processes and analytical research to assess the purity of Azilsartan formulations. Its presence can influence the pharmacokinetics and overall efficacy of the drug, making it relevant in stability studies and regulatory assessments. -
Drug Impurity
Azithromycin impurity 11, also known as 3'-N-Demethyl-3'-N-formylazithromycin, represents a significant impurity of the antibiotic Azithromycin. This compound is essential for analytical studies and the assessment of drug purity in pharmacological research. Its presence can impact the efficacy and safety profile of Azithromycin, making it crucial for quality control in the pharmaceutical industry. -
Drug Impurity
Alfuzosin EP impurity 4 is a known impurity associated with the pharmaceutical compound Alfuzosin, a selective alpha-1 adrenergic antagonist. This reagent is essential for quality control and analytical characterization in the development and manufacturing processes of Alfuzosin. It is employed in research applications aimed at understanding impurities in drug formulations and ensuring compliance with pharmacopoeial standards. -
Drug Impurity
Terbinafine impurity 2 hydrochloride is a chemical impurity associated with Terbinafine hydrochloride, primarily serving as a reference standard in pharmaceutical research. Its identification and characterization are crucial for quality control and validation processes in drug development. This compound aids in assessing the purity of Terbinafine hydrochloride and ensuring compliance with regulatory standards. -
Drug Impurity
Erlotinib impurity 45 is a notable impurity associated with Erlotinib, a potent inhibitor of the epidermal growth factor receptor (EGFR). This compound serves as a reference standard in analytical chemistry for the evaluation of drug purity and quality control in pharmaceutical research. Its presence is critical for assessing the safety and efficacy profiles of Erlotinib-containing formulations in drug development and regulatory compliance. -
Drug Impurity
Mycophenolate impurity 6 is a known impurity associated with Mycophenolate. This compound serves as a reference standard for assessing the purity of Mycophenolate in pharmaceutical formulations. Its presence is critical for ensuring quality control and compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Acebutolol impurity 3, also known as 2-Acetyl-4-butyramidophenol, is a recognized impurity associated with the pharmaceutical compound Acebutolol. This reagent is often utilized in analytical research to ensure the quality and purity of Acebutolol formulations. Its identification and characterization are crucial for compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Tenofovir impurity 19 is a characterized impurity of the antiviral compound Tenofovir, which acts as a nucleotide reverse transcriptase inhibitor. This impurity is critical for quality control and analytical purposes in pharmaceutical research and development. It aids in the assessment of the purity of Tenofovir formulations, ensuring compliance with safety and regulatory standards in drug manufacturing.
